Dexcom (DXCM) Other Working Capital Changes (2010 - 2026)

Dexcom (DXCM) has 17 years of Other Working Capital Changes data on file, last reported at -$51.0 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$51.0 million, down 209.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19.7 million (down 2914.29% YoY), and the FY2025 annual result was $14.8 million, up 155.17% from the prior year.
• Other Working Capital Changes eased to -$51.0 million in Q1 2026 per DXCM's latest filing, from $6.9 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $97.9 million in Q1 2022 and troughed at -$51.0 million in Q1 2026.
• A 5-year average of $4.8 million and a median of -$6.1 million in 2023 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 1525.81% in 2022, then plunged 1176.92% in 2023.
• A 5-year view of Other Working Capital Changes shows it stood at $50.4 million in 2022, then sank by 112.1% to -$6.1 million in 2023, then plunged by 31.15% to -$8.0 million in 2024, then jumped by 186.25% to $6.9 million in 2025, then slumped by 839.13% to -$51.0 million in 2026.
• Business Quant data shows DXCM's Other Working Capital Changes at -$51.0 million in Q1 2026, $6.9 million in Q4 2025, and $2.4 million in Q3 2025.